UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000039986
Receipt No. R000045582
Scientific Title Risk factors of death from coronavirus disease 2019
Date of disclosure of the study information 2020/03/31
Last modified on 2020/03/30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Risk factors of death from coronavirus disease 2019
Acronym Risk factors of death from coronavirus disease 2019
Scientific Title Risk factors of death from coronavirus disease 2019
Scientific Title:Acronym Risk factors of death from coronavirus disease 2019
Region
Japan

Condition
Condition COVID-19
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 World Health Organization declared pandemic of coronavirus disease 2019 (COVID-19) on March 11th, 2020. As of Mar 28th, more than 640,000 infected cases and 30,000 deaths were reported from 183 countries and territories. Currently, no vaccination and antivirus medication have been proved to be effective for prevention or treatment of this infectious disease. Rapidly expanding COVID-19 has led to social lock down and medical system collapse of some cities in China, South Korea, USA, Italy, Spain and other European countries. While each city or region has limited medical resources, it is known that young infected individuals who do not have any comorbidity usually recover without any medical care. Therefore, we should utilize limited medical resources such as beds, medication, human resources, respirators, and intensive care unit for people with high risk of death. Some published research papers revealed risk factor2 of death such as being a male, higher age, and smoking history. However, there was a considerable discrepancy among reports. The goal of this systematic review is to summarize the data of fetal risk from COVID-19.
Basic objectives2 Others
Basic objectives -Others To identify risk factor of death from COVID-19
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Odds ratio for death
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Individuals with COVID-19
Key exclusion criteria NA
Target sample size

Research contact person
Name of lead principal investigator
1st name Nobuyuki
Middle name
Last name Horita
Organization Yokohama City University
Division name Department of Pulmonology
Zip code 236-0004
Address 3-9, Fukuura, Kanazawa, Yokohama, Jaapn
TEL 0457872800
Email horitano@yokohama-cu.ac.jp

Public contact
Name of contact person
1st name Nobuyuki
Middle name
Last name Horita
Organization Yokohama City University
Division name Department of Pulmonology
Zip code 236-0004
Address 3-9, Fukuura, Kanazawa, Yokohama, Jaapn
TEL 0457872800
Homepage URL
Email horitano@yokohama-cu.ac.jp

Sponsor
Institute Yokohama City University
Institute
Department

Funding Source
Organization NA
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization NA
Address NA
Tel 0457872800
Email horitano@yokohama-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 03 Month 28 Day
Date of IRB
Anticipated trial start date
2020 Year 03 Month 28 Day
Last follow-up date
2020 Year 03 Month 28 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The protocol follows Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Institutional review board approval and patient consent were not required because of the review nature of this study. The protocol was registered at Japanese University hospital Medical Information Network (UMIN) Center.

We will systematically search PubMed, EMBASE, Web of Science and conduct hand searching using the following wordings: nCoV, COVID, 2019-nCoV, and SARS-CoV-2. Both prospective and retrospective study that provide data regarding risk factor for death among people with COVID-19. Two review authors will screen and full-text scrutinize to identify eligible articles.
A case report with less than five case was excluded from our analysis.

The primary outcome of our analysis is odds ratio for death for each risk factor compared to those without the risk factor.

Management information
Registered date
2020 Year 03 Month 30 Day
Last modified on
2020 Year 03 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.